Financing Transactions - Additional Information (Detail) (USD $)	9 Months Ended			1 Months Ended		9 Months Ended
	Sep. 30, 2012	Mar. 30, 2012	Dec. 31, 2011	Jun. 30, 2011 PharmAthene	Sep. 30, 2012 Percentage Over Libor	Sep. 30, 2012 Year One	Sep. 30, 2012 Year Two	Sep. 30, 2012 Year Three	Sep. 30, 2012 There After	Sep. 30, 2012 Term Loan	Mar. 30, 2012 Credit Facilities Term Loan	Sep. 30, 2012 Senior Secured Credit Facility Term Loans	Mar. 30, 2012 Senior Secured Credit Facility Term Loans Revolving Line Of Credit
Line of Credit Facility [Line Items]
Senior secured debt facility	$ 2,500,000										$ 2,500,000
Line of credit facility, maximum borrowing capacity													5,000,000
Line of Credit Facility, Amount Outstanding													1,200,000
Percentage of withdrawal from revolving loan qualified billed												85.00%
Percentage of withdrawal from revolving loan qualified unbilled												80.00%
Line of credit facility, Remaining borrowing capacity												1,300,000
Fixed interest rate on term loan	10.14%
Variable interest rate	1.50%
Fixed portion of the variable rate					5.00%
Interest rate on revolving line of credit	6.50%
Term loan and line of credit, maturity date	2015-09
Term loan , payment terms	Payments on the term loan are interest-only for the first 10 months, which may be extended to 12 months if certain conditions described in the Loan Agreement are met. Subsequently, the term loan will fully amortize over its remaining term.
Percentage of prepayment premium						3.00%	3.00%	2.00%	2.00%
Percentage of final payment premium										3.00%
Warrants issued to purchase shares of common stock	46,584	46,584		371,423
Common stock at an exercise price	1.61	1.61		3.50
Fair value attributable to the warrant	69,876
Warrant expiration date	Mar. 30, 2022	Mar. 30, 2022
Debt financing costs	216,000
Common Stock Share issued	48,345,984		48,236,172	1,857,143
Common Stock issued price				$ 3.50
Gross proceeds from issuance of stock				6,500,000
Net Proceeds from issuance of stock				$ 5,800,000